tirzepatide program near me Weight Loss — Dual GIP/GLP-1 Tirzepatide & Zepbound® Weight Loss

Many GLP-1 users have reported weight gain after ceasing GLP-1 use, while others have mentioned side effects like diarrhea, "paralyzed" stomachs, hair loss, and nausea

Patients cannot access retatrutide outside of clinical trials until FDA approval

Physician-tested on GLP-1 patients as a regimen with A.G.E

In a very small study of people who were newly diagnosed with type 1 diabetes, all 10 participants were able to stop taking mealtime insulin after three months of treatment with low-dose Ozempic (semaglutide 0.5 mg)

Diabetes: working to reverse the US epidemic at a glance 2016

Another clinical trial examining these two drugs head-to-head is expected to complete in late 2024